Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.48487 | 57 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.20623 | 50 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.2099 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15084 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.11664 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.43691 | 54 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.34959 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.18309 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.14517 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.16563 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.19671 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.17561 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.22544 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.2026 | 50 |